BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32383028)

  • 1. Phenformin inhibits proliferation, invasion, and angiogenesis of cholangiocarcinoma cells via AMPK-mTOR and HIF-1A pathways.
    Jaidee R; Kongpetch S; Senggunprai L; Prawan A; Kukongviriyapan U; Kukongviriyapan V
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Sep; 393(9):1681-1690. PubMed ID: 32383028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin enhances cisplatin induced inhibition of cholangiocarcinoma cells via AMPK-mTOR pathway.
    Wandee J; Prawan A; Senggunprai L; Kongpetch S; Tusskorn O; Kukongviriyapan V
    Life Sci; 2018 Aug; 207():172-183. PubMed ID: 29847773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Jianpi Jiedu decoction, a traditional Chinese medicine formula, inhibits tumorigenesis, metastasis, and angiogenesis through the mTOR/HIF-1α/VEGF pathway.
    Peng W; Zhang S; Zhang Z; Xu P; Mao D; Huang S; Chen B; Zhang C; Zhang S
    J Ethnopharmacol; 2018 Oct; 224():140-148. PubMed ID: 29852266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of FGFR2 enhances chemosensitivity to gemcitabine in cholangiocarcinoma through the AKT/mTOR and EMT signaling pathways.
    Jaidee R; Kukongviriyapan V; Senggunprai L; Prawan A; Jusakul A; Laphanuwat P; Kongpetch S
    Life Sci; 2022 May; 296():120427. PubMed ID: 35218764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salidroside improves angiogenesis-osteogenesis coupling by regulating the HIF-1α/VEGF signalling pathway in the bone environment.
    Guo Q; Yang J; Chen Y; Jin X; Li Z; Wen X; Xia Q; Wang Y
    Eur J Pharmacol; 2020 Oct; 884():173394. PubMed ID: 32730833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
    Chen MC; Lee CF; Huang WH; Chou TC
    Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Derrischalcone suppresses cholangiocarcinoma cells through targeting ROS-mediated mitochondrial cell death, Akt/mTOR, and FAK pathways.
    Wandee J; Srinontong P; Prawan A; Senggunprai L; Kongpetch S; Yenjai C; Kukongviriyapan V
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Sep; 394(9):1929-1940. PubMed ID: 34086099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Notoginsenoside Ft1 promotes angiogenesis via HIF-1α mediated VEGF secretion and the regulation of PI3K/AKT and Raf/MEK/ERK signaling pathways.
    Shen K; Ji L; Gong C; Ma Y; Yang L; Fan Y; Hou M; Wang Z
    Biochem Pharmacol; 2012 Sep; 84(6):784-92. PubMed ID: 22771629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apatinib affect VEGF-mediated cell proliferation, migration, invasion via blocking VEGFR2/RAF/MEK/ERK and PI3K/AKT pathways in cholangiocarcinoma cell.
    Huang M; Huang B; Li G; Zeng S
    BMC Gastroenterol; 2018 Nov; 18(1):169. PubMed ID: 30400838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antihypertension drug doxazosin inhibits tumor growth and angiogenesis by decreasing VEGFR-2/Akt/mTOR signaling and VEGF and HIF-1α expression.
    Park MS; Kim BR; Dong SM; Lee SH; Kim DY; Rho SB
    Oncotarget; 2014 Jul; 5(13):4935-44. PubMed ID: 24952732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer.
    Sui H; Zhao J; Zhou L; Wen H; Deng W; Li C; Ji Q; Liu X; Feng Y; Chai N; Zhang Q; Cai J; Li Q
    Cancer Lett; 2017 Sep; 403():86-97. PubMed ID: 28602978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin Exerts Antiproliferative and Anti-metastatic Effects Against Cholangiocarcinoma Cells by Targeting STAT3 and NF-ĸB.
    Saengboonmee C; Seubwai W; Cha'on U; Sawanyawisuth K; Wongkham S; Wongkham C
    Anticancer Res; 2017 Jan; 37(1):115-123. PubMed ID: 28011481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryptotanshinone inhibits VEGF-induced angiogenesis by targeting the VEGFR2 signaling pathway.
    Xu X; Wu L; Zhou X; Zhou N; Zhuang Q; Yang J; Dai J; Wang H; Chen S; Mao W
    Microvasc Res; 2017 May; 111():25-31. PubMed ID: 28040437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenformin and ataxia-telangiectasia mutated inhibitors synergistically co-suppress liver cancer cell growth by damaging mitochondria.
    Wu T; Zhou S; Qin M; Tang J; Yan X; Huang L; Huang M; Deng J; Xiao D; Hu X; Wu J; Yang X; Li G
    FEBS Open Bio; 2021 May; 11(5):1440-1451. PubMed ID: 33742560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capsaicin suppresses the migration of cholangiocarcinoma cells by down-regulating matrix metalloproteinase-9 expression via the AMPK-NF-κB signaling pathway.
    Lee GR; Jang SH; Kim CJ; Kim AR; Yoon DJ; Park NH; Han IS
    Clin Exp Metastasis; 2014 Dec; 31(8):897-907. PubMed ID: 25217963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pomolic acid suppresses HIF1α/VEGF-mediated angiogenesis by targeting p38-MAPK and mTOR signaling cascades.
    Park JH; Yoon J; Park B
    Phytomedicine; 2016 Dec; 23(14):1716-1726. PubMed ID: 27912873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenformin inhibits cell proliferation and induces cell apoptosis and autophagy in cholangiocarcinoma.
    Hu S; Ouyang Q; Cheng Q; Wang J; Feng F; Qiao L; Gan W; Shi Y; Wu D; Jiang X
    Mol Med Rep; 2018 Apr; 17(4):6028-6032. PubMed ID: 29436644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquiritigenin inhibits serum-induced HIF-1α and VEGF expression via the AKT/mTOR-p70S6K signalling pathway in HeLa cells.
    Xie SR; Wang Y; Liu CW; Luo K; Cai YQ
    Phytother Res; 2012 Aug; 26(8):1133-41. PubMed ID: 22170854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. gamma-Aminobutyric acid inhibits cholangiocarcinoma growth by cyclic AMP-dependent regulation of the protein kinase A/extracellular signal-regulated kinase 1/2 pathway.
    Fava G; Marucci L; Glaser S; Francis H; De Morrow S; Benedetti A; Alvaro D; Venter J; Meininger C; Patel T; Taffetani S; Marzioni M; Summers R; Reichenbach R; Alpini G
    Cancer Res; 2005 Dec; 65(24):11437-46. PubMed ID: 16357152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bp5250 inhibits vascular endothelial growth factor-induced angiogenesis and HIF-1α expression on endothelial cells.
    Lin KT; Lien JC; Chung CH; Kuo SC; Huang TF
    Naunyn Schmiedebergs Arch Pharmacol; 2012 Jan; 385(1):39-49. PubMed ID: 21947252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.